Nianping Chen

567 citations

18 papers · 457 indexed · h-index 12

Impact in

Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Complementary and alternative medicine top 10%
- Medicinal plant effects and applications

Papers in ⓘ

Molecular Biology 8
- Biological Activity of Diterpenoids and Biflavonoids 2
Oncology 7
- Cancer-related Molecular Pathways 4
- PARP inhibition in cancer therapy 2

Co-authors: Mingyi Li (10 shared papers)Runzhi Zhu (6 shared papers)Jie Liu (4 shared papers)Qingyu Zhang (4 shared papers)Huilai Miao (7 shared papers)Juan Xia (2 shared papers)Juntao Liu (2 shared papers)Qingyu Zhang (2 shared papers)
Journals: International Journal of Surgery (1 paper)Journal of Cellular Biochemistry (1 paper)Scientific Reports (1 paper)BMC Surgery (1 paper)Oncology Reports (1 paper)
Partner nations: China Hong Kong Iran

In The Last Decade

Nianping Chen

18 papers receiving 453 citations

Peers

Countries citing papers authored by Nianping Chen

Since Specialization

Citations

This map shows the geographic impact of Nianping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianping Chen more than expected).

Fields of papers citing papers by Nianping Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nianping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianping Chen. The network helps show where Nianping Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Nianping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nianping Chen Line = papers co-authored together Nianping Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S-phase cell cycle arrest and apoptosis through caspase/cyclin-CDK pathways Molecular Medicine Reports ·Bin Liu, Zhongyou Zhou, Wei Zhou, Jie Liu, Qingyu Zhang, Juan Xia, Juntao Liu, Nianping Chen, Mingyi Li, Runzhi Zhu	2014	72
2	Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism Scientific Reports ·Qingyu Zhang, Jie Liu, Bin Liu, Juan Xia, Nianping Chen, Xiaofeng Chen, Yi Cao, Chen Zhang, Caijie Lu, Mingyi Li, Runzhi Zhu	2014	67
3	Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis Molecular Medicine Reports ·Zhiyuan Wu, Bin Liu, E Cailing, Jie Liu, Qingyu Zhang, Juntao Liu, Nianping Chen, Rongyi Chen, Runzhi Zhu	2014	50
4	Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma Oncotarget ·Qingyu Zhang, Caijie Lu, Tao Fang, Yongcun Wang, Wenhua Hu, Jie Qiao, Bin Liu, Jie Liu, Nianping Chen, Mingyi Li, Runzhi Zhu	2015	44
5	AZD8055 induces cell death associated with autophagy and activation of AMPK in hepatocellular carcinoma Oncology Reports ·Min Hu, Haili Huang, Rui Zhao, Peng Li, Mingyi Li, Huilai Miao, Nianping Chen, Ming Chen	2013	42
6	Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down‐regulation of YAP Journal of Cellular Biochemistry ·Huilai Miao, Zhijian Pan, Changjiang Lei, Jinhua Wen, Mingyi Li, Zhong‐Kao Liu, Zhidong Qiu, Manzhou Lin, Nianping Chen, Ming Chen	2012	40
7	Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway Molecular Medicine Reports ·Bin Liu, Wei Zhou, Xiaofeng Chen, Fengming Xu, Yinqin Chen, Jie Liu, Qingyu Zhang, Shiting Bao, Nianping Chen, Mingyi Li, Runzhi Zhu	2014	27
8	CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma Molecular Medicine Reports ·Wei Dai, Huilai Miao, Shuo Fang, Tao Fang, Nianping Chen, Mingyi Li	2016	26
9	Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells Molecular Medicine Reports ·Bin Liu, Yufeng Shi, WENDING PENG, Qingyu Zhang, Jie Liu, Nianping Chen, Runzhi Zhu	2016	23
10	Acoustic Radiation Force Impulse Elastography for Efficacy Evaluation after Hepatocellular Carcinoma Radiofrequency Ablation: A Comparative Study with Contrast-Enhanced Ultrasound BioMed Research International ·Xiaohong Xu, Liangping Luo, Jiexin Chen, Jiexin Wang, Honglian Zhou, Mingyi Li, Zhanqiang Jin, Nianping Chen, Huilai Miao, Manzhou Lin, Wei Dai, Anil T. Ahuja, Yì Wáng	2014	13
11	Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma Cancer Medicine ·Xiao‐Guang Liu, Hao Xu, Ming Chen, Xiaoyu Tan, Xiaofeng Chen, Yong‐Guang Yang, Manzhou Lin, Guohua Liu, Xiaolu Liang, Yi‐Bin Qian, Guojia Yuan, Min‐Qiang Chen, Wentao Li, Huilai Miao, Mingyi Li, Xiwen Liao, Wei Dai, Nianping Chen	2020	12
12	The landscape of PD-L1 expression and somatic mutations in hepatocellular carcinoma Journal of Gastrointestinal Oncology ·Hao Xu, Xiaolu Liang, Xiaoguang Liu, Nianping Chen	2021	11
13	Lenvatinib plus drug-eluting bead transarterial chemoembolization with/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study International Journal of Surgery ·Mingyue Cai, Licong Liang, Jian Zhang, Nianping Chen, Wensou Huang, Yongjian Guo, Xiaotao Hong, Liteng Lin, Yaohong Liu, Dan Cao, Haihui Deng, Margaret Liu, Jingwen Zhou, Ye Chen, Huanwei Chen, Kangshun Zhu	2024	9
14	CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma in vitro Journal of International Medical Research ·Wei Dai, Shuo Fang, Guanhe Cai, Jialiang Dai, Guotai Lin, Qiurong Ye, Huilai Miao, Ming Chen, Xiaoyu Tan, Nianping Chen, Xiaoguang Liu, Mingyi Li	2020	9
15	Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis Open Life Sciences ·Jianbo Peng, Shuo Fang, Meisheng Li, Yuxin Liu, Xiaolu Liang, Zuobiao Li, Gaohui Chen, Lijiao Peng, Nianping Chen, Lei Liu, Xiaohong Xu, Wei Dai	2023	6
16	Giant recurrent left inguinal hernia with femoral nerve injury: a report of a rare case BMC Surgery ·Manzhou Lin, Guojie Long, Ming Chen, Weice Chen, Jian Mo, Nianping Chen	2020	3
17	MicroRNAs: Crucial Players in the Differentiation of Human Pluripotentand Multipotent Stem Cells into Functional Hepatocyte-Like Cells Current Stem Cell Research & Therapy ·Liying Wu, Maryam Farzaneh, Hao Xu, Guojia Yuan, Xiaolu Liang, Xiaoguang Liu, Zuobiao Li, Nianping Chen	2021	2
18	Comparison of laparoscopic radiofrequency ablation with percutaneous radiofrequency ablation in the treatment of chronic hepatitis B-related hepatocellular carcinoma involving specific sites: A retrospective cohort study Asian Journal of Surgery ·Wei Dai, Shuo Fang, Cong Mo, Yuxin Liu, Tingyun Shen, Mingyi Li, Honglian Zhou, Huilai Miao, Ming Chen, Xiaoyu Tan, Shiting Bao, Xiaohong Xu, Nianping Chen	2023	1

About Nianping Chen

Nianping Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Hepatology and Geriatrics and Gerontology, having authored 18 papers that have together received 457 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer, Lipids, and Metabolism (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Medicinal plant effects and applications (2 papers), Biological Activity of Diterpenoids and Biflavonoids (2 papers), Ferroptosis and cancer prognosis (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Geriatrics and Gerontology (60 citations), Complementary and alternative medicine (65 citations), Cancer Research (96 citations), Hepatology (48 citations) and Physiology (19 citations). Nianping Chen has collaborated with scholars based in China, Hong Kong and Iran. Frequent co-authors include Mingyi Li, Runzhi Zhu, Jie Liu, Qingyu Zhang, Huilai Miao, Juan Xia, Juntao Liu, Qingyu Zhang, Wei Zhou and Bin Liu. Their work appears in journals such as International Journal of Surgery, Journal of Cellular Biochemistry, Scientific Reports, BMC Surgery and Oncology Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact